Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Miller

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
STAR Protocols|September 6, 2022
Protocol for isolation and characterization of lung tissue resident memory T cells and airway trained innate immunity after intranasal vaccination in miceMichael R D'Agostino, Sam Afkhami, Alisha Kang, et al.
Nature Reviews. Immunology|December 19, 2022
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infectionAli Zhang, Hannah D Stacey, Michael R D'Agostino, et al.
Human Vaccines & Immunotherapeutics|November 18, 2024
Seasonal influenza vaccines: Variability of immune responses to B lineage virusesMatthew S Miller, Emanuele Montomoli, Eyal Leshem, et al.
Journal of Veterinary Internal Medicine|October 7, 2020
Association between vitamin D metabolites, vitamin D binding protein, and proteinuria in dogsMatthew S Miller, Adam J Rudinsky, Brett G Klamer, et al.
The Journal of Infectious Diseases|April 2, 2016
Autoimmune Variant PTPN22 C1858T Is Associated With Impaired Responses to Influenza VaccinationJuliet N Crabtree, Wenqian He, Weihua Guan, et al.
Vaccines|July 2, 2021
Neutrophils and Influenza: A Thin Line between Helpful and HarmfulSneha T George, Jonathan Lai, Julia Ma, et al.
Journal of Virology|January 16, 2015
Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbonesWenqian He, Caitlin E Mullarkey, J Andrew Duty, et al.
The Journal of Infectious Diseases|October 23, 2012
1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humansMatthew S Miller, Tshidi Tsibane, Florian Krammer, et al.
The Journal of Infectious Diseases|November 6, 2024
Hemagglutination-Inhibition Antibodies and Protection against Influenza Elicited by Inactivated and Live Attenuated Vaccines in ChildrenSergey Yegorov, Angela Brewer, Louis Cyr, et al.
Msphere|February 28, 2022
Adenovirus 5 Vectors Expressing SARS-CoV-2 ProteinsScott Bachus, Nikolas Akkerman, Lauren Fulham, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
STAR Protocols|September 6, 2022
Protocol for isolation and characterization of lung tissue resident memory T cells and airway trained innate immunity after intranasal vaccination in miceMichael R D'Agostino, Sam Afkhami, Alisha Kang, et al.
Nature Reviews. Immunology|December 19, 2022
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infectionAli Zhang, Hannah D Stacey, Michael R D'Agostino, et al.
Human Vaccines & Immunotherapeutics|November 18, 2024
Seasonal influenza vaccines: Variability of immune responses to B lineage virusesMatthew S Miller, Emanuele Montomoli, Eyal Leshem, et al.
Journal of Veterinary Internal Medicine|October 7, 2020
Association between vitamin D metabolites, vitamin D binding protein, and proteinuria in dogsMatthew S Miller, Adam J Rudinsky, Brett G Klamer, et al.
The Journal of Infectious Diseases|April 2, 2016
Autoimmune Variant PTPN22 C1858T Is Associated With Impaired Responses to Influenza VaccinationJuliet N Crabtree, Wenqian He, Weihua Guan, et al.
Vaccines|July 2, 2021
Neutrophils and Influenza: A Thin Line between Helpful and HarmfulSneha T George, Jonathan Lai, Julia Ma, et al.
Journal of Virology|January 16, 2015
Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbonesWenqian He, Caitlin E Mullarkey, J Andrew Duty, et al.
The Journal of Infectious Diseases|October 23, 2012
1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humansMatthew S Miller, Tshidi Tsibane, Florian Krammer, et al.
The Journal of Infectious Diseases|November 6, 2024
Hemagglutination-Inhibition Antibodies and Protection against Influenza Elicited by Inactivated and Live Attenuated Vaccines in ChildrenSergey Yegorov, Angela Brewer, Louis Cyr, et al.
Msphere|February 28, 2022
Adenovirus 5 Vectors Expressing SARS-CoV-2 ProteinsScott Bachus, Nikolas Akkerman, Lauren Fulham, et al.
Pageof 12